H. Okuno, S. Fukushima, T. Hirota, M. Takasu, Y. Shiozaki, Kyoichi Inoue
{"title":"缺乏干扰素对人肝脏药物代谢活性的体外影响","authors":"H. Okuno, S. Fukushima, T. Hirota, M. Takasu, Y. Shiozaki, Kyoichi Inoue","doi":"10.5361/JKMU1956.47.1-2_72","DOIUrl":null,"url":null,"abstract":"The in vitro effects of interferon (IFN) on drug—metabolizing activity in the human liver were investigated. The activities of 7-methoxycoumarin (7-MC) O-demethylase and 7-ethoxycoumarin (7-EC) Odeethylase in liver microsomes were measured in the absence and presence of IFN-a 2a. The peak blood concentration reached during clinical IFN-a 2a treatment has been reported to be 101 to 103 IU/ml. At a high concentration (106 IU/ml), IFN-a 2a inhibited the activities of both enzymes, to 75.6% and 72.4% of the control activity, respectively, but few effects were observed at concentrations of 101 to 105 IU/ml. These results indicate that the depression of drug metabolism during IFN treatment is not due to the direct inhibition of drug—metabolizing enzymes by IFN molecules, but that other factor(s) are needed for IFN to exhibit this action.","PeriodicalId":281939,"journal":{"name":"The journal of Kansai Medical University","volume":"35 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1995-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Lack of in vitro effects of interferon on drug-metabolizing activity in the human liver\",\"authors\":\"H. Okuno, S. Fukushima, T. Hirota, M. Takasu, Y. Shiozaki, Kyoichi Inoue\",\"doi\":\"10.5361/JKMU1956.47.1-2_72\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The in vitro effects of interferon (IFN) on drug—metabolizing activity in the human liver were investigated. The activities of 7-methoxycoumarin (7-MC) O-demethylase and 7-ethoxycoumarin (7-EC) Odeethylase in liver microsomes were measured in the absence and presence of IFN-a 2a. The peak blood concentration reached during clinical IFN-a 2a treatment has been reported to be 101 to 103 IU/ml. At a high concentration (106 IU/ml), IFN-a 2a inhibited the activities of both enzymes, to 75.6% and 72.4% of the control activity, respectively, but few effects were observed at concentrations of 101 to 105 IU/ml. These results indicate that the depression of drug metabolism during IFN treatment is not due to the direct inhibition of drug—metabolizing enzymes by IFN molecules, but that other factor(s) are needed for IFN to exhibit this action.\",\"PeriodicalId\":281939,\"journal\":{\"name\":\"The journal of Kansai Medical University\",\"volume\":\"35 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1995-06-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The journal of Kansai Medical University\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5361/JKMU1956.47.1-2_72\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The journal of Kansai Medical University","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5361/JKMU1956.47.1-2_72","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
研究了干扰素(IFN)对人肝脏药物代谢活性的体外影响。在IFN-a - 2a缺失和存在的情况下,测定肝微粒体中7-甲氧基香豆素(7-MC) o -去甲基化酶和7-乙氧基香豆素(7-EC) o -去甲基化酶的活性。据报道,临床IFN-a - 2a治疗期间达到的血药浓度峰值为101 ~ 103 IU/ml。高浓度(106 IU/ml)时,IFN-a - 2a对这两种酶的抑制作用分别为对照的75.6%和72.4%,但在101 ~ 105 IU/ml浓度时影响不大。这些结果表明,在IFN治疗期间药物代谢的抑制不是由于IFN分子对药物代谢酶的直接抑制,而是IFN需要其他因素才能发挥这种作用。
Lack of in vitro effects of interferon on drug-metabolizing activity in the human liver
The in vitro effects of interferon (IFN) on drug—metabolizing activity in the human liver were investigated. The activities of 7-methoxycoumarin (7-MC) O-demethylase and 7-ethoxycoumarin (7-EC) Odeethylase in liver microsomes were measured in the absence and presence of IFN-a 2a. The peak blood concentration reached during clinical IFN-a 2a treatment has been reported to be 101 to 103 IU/ml. At a high concentration (106 IU/ml), IFN-a 2a inhibited the activities of both enzymes, to 75.6% and 72.4% of the control activity, respectively, but few effects were observed at concentrations of 101 to 105 IU/ml. These results indicate that the depression of drug metabolism during IFN treatment is not due to the direct inhibition of drug—metabolizing enzymes by IFN molecules, but that other factor(s) are needed for IFN to exhibit this action.